Cycle Oncology
Supporting choice in oncology care.
At Cycle Pharmaceuticals, we are committed to helping people living with cancer access treatment options that fit their individual needs.
CAVHANZA™ (nilotinib) Orally Disintegrating Tablets
Approved in the US.
Prescribing Information, including boxed warning
Discover CAVHANZA
Patient Support Program
Life-changing treatments need life-improving product support to match. That’s why we created Cycle Vita™, our patient support program for patients in the US. It delivers individualized emotional, financial,* and product support that patients need at every step of their journey.
*Some areas of support may not be accessible to all patients. Eligibility criteria may apply to ensure compliance with all applicable federal and state requirements, and benefits may be limited to commercially insured patients only. For more detailed information about eligibility, terms and conditions, please contact the Cycle Vita team at 888-360-8482.